Real-World Evidence: Considerations Regarding Non-Interventional Studies for Drug and Biological Products; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Real-World Evidence: Considerations Regarding Non-Interventional Studies for Drug and Biological Products; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 770d ago.

Abstract

OPEN

Commenters (1)

• Consumer Healthcare Products Associationtrade assoc.

  1 filing · confidence 97%